Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
TAA-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
Recruiting1 awardPhase 1
Houston, Texas
This trial is for patients with Multiple Myeloma, monoclonal gammopathy of undetermined significance (MGUS), or smoldering myeloma (SM). The goal is to find the largest safe dose of TAA-specific CTLs (a new experimental therapy), and to see whether it might help patients by targeting proteins that are expressed by cancer cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.